CRL SEC Filing News — Charles River Laboratories International, Inc.

CRL insider Parisotto Shannon M (CEVP, Disc & Safety Assessment) sold 981 shares (~$302.6K)

Parisotto Shannon M, listed as CEVP, Disc & Safety Assessment at CHARLES RIVER LABORATORIES INTERNATIONAL, INC., reported an open-market sale of 981 CRL shares in a Form 4 filing. This is a confirmed insider sale, not just a proposed sale notice.

The insider sold shares on the open market. Sales may be discretionary or executed automatically under a pre-arranged Rule 10b5-1 trading plan, and a Form 4 does not always make clear which applies.

CRL insider Coleman Glenn (EVP & Chief Financial Officer) bought 10 shares (~$3.0K)

Coleman Glenn, listed as EVP & Chief Financial Officer at CHARLES RIVER LABORATORIES INTERNATIONAL, INC., reported an open-market purchase of 10 CRL shares in a Form 4 filing. Insider buying is often treated as a bullish signal because company insiders are committing their own capital.

The insider bought shares on the open market with their own money. This is the only Form 4 category that requires a discretionary cash outlay at the prevailing price.

CRL insider FOSTER JAMES C (Director) sold 33,561 shares (~$10.07M)

FOSTER JAMES C, listed as Director at CHARLES RIVER LABORATORIES INTERNATIONAL, INC., reported an open-market sale of 33,561 CRL shares in a Form 4 filing. This is a confirmed insider sale, not just a proposed sale notice.

The insider sold shares on the open market. Sales may be discretionary or executed automatically under a pre-arranged Rule 10b5-1 trading plan, and a Form 4 does not always make clear which applies.

CRL insider Form 4 filed for equity award, exercise, or tax withholding

Girshick Birgit (Director, Chief Executive Officer) filed a Form 4 covering compensation-related activity such as stock awards, option exercises, conversions, or tax withholding. These filings are usually neutral.

Shares were transferred as a gift, typically for estate or charitable planning. No sale into the market took place.

CRL insider Parisotto Shannon M (CEVP, Disc & Safety Assessment) sold 2,039 shares (~$599.7K)

Parisotto Shannon M, listed as CEVP, Disc & Safety Assessment at CHARLES RIVER LABORATORIES INTERNATIONAL, INC., reported an open-market sale of 2,039 CRL shares in a Form 4 filing. This is a confirmed insider sale, not just a proposed sale notice.

The insider sold shares on the open market. Sales may be discretionary or executed automatically under a pre-arranged Rule 10b5-1 trading plan, and a Form 4 does not always make clear which applies.

CRL insider Andrews Nancy C (Director) sold 573 shares (~$163.4K)

Andrews Nancy C, listed as Director at CHARLES RIVER LABORATORIES INTERNATIONAL, INC., reported an open-market sale of 573 CRL shares in a Form 4 filing. This is a confirmed insider sale, not just a proposed sale notice.

The insider sold shares on the open market. Sales may be discretionary or executed automatically under a pre-arranged Rule 10b5-1 trading plan, and a Form 4 does not always make clear which applies.

CRL insider Girshick Birgit (Director, Chief Executive Officer) sold 6,500 shares (~$1.82M)

Girshick Birgit, listed as Director, Chief Executive Officer at CHARLES RIVER LABORATORIES INTERNATIONAL, INC., reported an open-market sale of 6,500 CRL shares in a Form 4 filing. This is a confirmed insider sale, not just a proposed sale notice.

The insider sold shares on the open market. Sales may be discretionary or executed automatically under a pre-arranged Rule 10b5-1 trading plan, and a Form 4 does not always make clear which applies.

CRL insider Parisotto Shannon M (CEVP, Disc & Safety Assessment) sold 3,714 shares (~$1.04M)

Parisotto Shannon M, listed as CEVP, Disc & Safety Assessment at CHARLES RIVER LABORATORIES INTERNATIONAL, INC., reported an open-market sale of 3,714 CRL shares in a Form 4 filing. This is a confirmed insider sale, not just a proposed sale notice.

The insider sold shares on the open market. Sales may be discretionary or executed automatically under a pre-arranged Rule 10b5-1 trading plan, and a Form 4 does not always make clear which applies.

CRL insider Form 4 filed for equity award, exercise, or tax withholding

LaPlume Joseph W (EVP, Corp Strategy & Develop) filed a Form 4 covering compensation-related activity such as stock awards, option exercises, conversions, or tax withholding. These filings are usually neutral.

Shares were transferred as a gift, typically for estate or charitable planning. No sale into the market took place.

CRL insider FOSTER JAMES C (Director) sold 28,733 shares (~$7.90M)

FOSTER JAMES C, listed as Director at CHARLES RIVER LABORATORIES INTERNATIONAL, INC., reported an open-market sale of 28,733 CRL shares in a Form 4 filing. This is a confirmed insider sale, not just a proposed sale notice.

The insider sold shares on the open market. Sales may be discretionary or executed automatically under a pre-arranged Rule 10b5-1 trading plan, and a Form 4 does not always make clear which applies.

CRL insider Knell Michael Gunnar (SVP, Finance and CAO) sold 6,645 shares (~$1.73M)

Knell Michael Gunnar, listed as SVP, Finance and CAO at CHARLES RIVER LABORATORIES INTERNATIONAL, INC., reported an open-market sale of 6,645 CRL shares in a Form 4 filing. This is a confirmed insider sale, not just a proposed sale notice.

The insider sold shares on the open market. Sales may be discretionary or executed automatically under a pre-arranged Rule 10b5-1 trading plan, and a Form 4 does not always make clear which applies.

CRL insider Creamer Victoria L (EVP & Chief People Officer) sold 4,179 shares (~$1.08M)

Creamer Victoria L, listed as EVP & Chief People Officer at CHARLES RIVER LABORATORIES INTERNATIONAL, INC., reported an open-market sale of 4,179 CRL shares in a Form 4 filing. This is a confirmed insider sale, not just a proposed sale notice.

The insider sold shares on the open market. Sales may be discretionary or executed automatically under a pre-arranged Rule 10b5-1 trading plan, and a Form 4 does not always make clear which applies.

CRL Form 144 filed for proposed insider sale by Parisotto Shannon M (981 shares) ~$308.6K

Parisotto Shannon M filed a Form 144 with the SEC indicating intent to sell CRL (CHARLES RIVER LABORATORIES INTERNATIONAL, INC.) shares. Form 144 reflects a proposed sale, not a completed transaction. The actual execution, if any, would typically appear later in a Form 4.

CRL Form 144 filed for proposed insider sale by FOSTER JAMES C (33,561 shares) ~$10.07M

FOSTER JAMES C filed a Form 144 with the SEC indicating intent to sell CRL (CHARLES RIVER LABORATORIES INTERNATIONAL, INC.) shares. Form 144 reflects a proposed sale, not a completed transaction. The actual execution, if any, would typically appear later in a Form 4. The proposed dollar value is large enough to merit attention.

CRL Form 144 filed for proposed insider sale by Parisotto Shannon M (2,039 shares) ~$599.7K

Parisotto Shannon M filed a Form 144 with the SEC indicating intent to sell CRL (CHARLES RIVER LABORATORIES INTERNATIONAL, INC.) shares. Form 144 reflects a proposed sale, not a completed transaction. The actual execution, if any, would typically appear later in a Form 4.

CRL Form 144 filed for proposed insider sale by Nancy C Andrews (573 shares) ~$163.3K

Nancy C Andrews filed a Form 144 with the SEC indicating intent to sell CRL (CHARLES RIVER LABORATORIES INTERNATIONAL, INC.) shares. Form 144 reflects a proposed sale, not a completed transaction. The actual execution, if any, would typically appear later in a Form 4.

CRL Form 144 filed for proposed insider sale by Parisotto Shannon M (3,714 shares) ~$1.04M

Parisotto Shannon M filed a Form 144 with the SEC indicating intent to sell CRL (CHARLES RIVER LABORATORIES INTERNATIONAL, INC.) shares. Form 144 reflects a proposed sale, not a completed transaction. The actual execution, if any, would typically appear later in a Form 4.

CRL Form 144 filed for proposed insider sale by Girshick Birgit (6,500 shares) ~$1.82M

Girshick Birgit filed a Form 144 with the SEC indicating intent to sell CRL (CHARLES RIVER LABORATORIES INTERNATIONAL, INC.) shares. Form 144 reflects a proposed sale, not a completed transaction. The actual execution, if any, would typically appear later in a Form 4.

CRL Form 144 filed for proposed insider sale by FOSTER JAMES C (28,733 shares) ~$7.90M

FOSTER JAMES C filed a Form 144 with the SEC indicating intent to sell CRL (CHARLES RIVER LABORATORIES INTERNATIONAL, INC.) shares. Form 144 reflects a proposed sale, not a completed transaction. The actual execution, if any, would typically appear later in a Form 4. The proposed dollar value is large enough to merit attention.

CRL filed 8-K — material company event

CHARLES RIVER LABORATORIES INTERNATIONAL, INC. filed an 8-K with the SEC reporting a material event. Summary unavailable — view the original SEC filing for the full text.